Taken together, these observations indicate that aberrancies in the MTSS1 degradation pathway, either by elevated expression of β-TRCP, or hyper-activation of CKIδ, may possibly downregulate the MTSS1 tumor suppressor to facilitate tumor cell growth and cancer progression (Figure 8). The gene discussed is MTSS1; the disease is neoplasm.